Regorafenib for patients with progression of advanced hepatocellular carcinoma after treatment with atezolizumab plus bevacizumab: a case series

Wendi Kang, Hongjiang Fu, Yingen Luo, Danielle M. Noreika, Tianhao Cong, Hang Li, Zhengqiang Yang